Windhover
Home
Home		 Register
Register		 Login
Log In		 Schedule
Schedule		 Information
Info		 Attending Companies
Attendees		 Contact
Contact		 Help
Help
October 27-29 2010Grand Hyatt San FranciscoSan Francisco, California

 

Announcing Elsevier’s 40th IN3 medical device partnering conference – A special ‘Ruby’ anniversary celebration – with some exciting program changes!

 

Elsevier is proud to introduce a completely new and improved conference format addressing various suggestions expressed by past attendees. We've integrated Investor Day with the main program, and the conference is now a full, 3 days of start-up presentations, investor presentations, and key plenary/panel sessions. The beneficial changes include:

  1. Medtech innovators can now present in the same time block as VCs. Get in front of the best potential suitor!
  2. Conference fees have been reduced. Take advantage of the more flexible registration options, such as investor pricing, one-day passes and complete hotel/conference packages.
  3. More “lessons learned” practical advice on the hottest financing and M&A deals. Hear our highlighted session called Case Studies of Recent Exit Strategies/M&As.

In the modern economy, medical device start-ups face intense competition for a finite amount of available capital funding. This makes IN3 events the ideal setting for emerging companies to meet and impress potential investors from many of the top-tier device companies and discerning healthcare investment firms from around the world.


IN3 Summit 2010 is a must-attend event if you are…
  • • An emerging company interested in what investment leaders in the industry are thinking, doing, and planning. Top-tier venture capitalists and corporate acquirers address what interests them most in innovative technologies, therapeutic areas, products, and geographic markets. They will also discuss partnering opportunities, case studies, how to maximize visibility in front of large company investors, and the role of M&A.
  • • A business development or financial community leader interested in investment, partnering, or acquisition opportunities with cutting-edge medtech innovators.
  • • A service provider or industry affiliate who is seeking to meet and support innovators and market leaders with their business needs.

In between presentation blocks, benefit from dedicated, 30-minute, break-out sessions for coffee socials, one-on-one private meetings, use of Windhover’s special partnering software, or networking throughout the duration of the event.

Testimonials

"IN3 East gave me the opportunity to sit face-to-face with a potential corporate partner and several other high-quality investors,” said Robert Stuba, President and CEO of MAX Endoscopy. “This represents good value, and I am therefore inclined to present at a future IN3 event."
"IN3 investor conferences are more important than ever, given a continuing difficult environment for medical technology companies,” said Brian Duncan, M.D., Venture Partner, Arboretum Ventures. “IN3 meetings provide a top-flight forum in which investors can efficiently observe advanced technologies at early stages of development."
“We are a continuing sponsor of Elsevier investor conferences,” added Kevin Schimelfenig, Managing Director, SalesForce4Hire. “The outstanding quality of the presenting companies is a great place in which to identify potential blockbuster medical devices and also a great place to bring medtech buyers and sellers together.”

Over 1,500 emerging medical technology company presenters and more than 8,000 attendees have participated at IN3 events over the past ten years. We are very proud to say that many young companies have worked their way up the funding ladder and into the marketplace via the relationships they formed at IN3 events. Click Here for success stories and testimonials from our past presenters and attendees.

 

For more information, please contact:
Kristy Kennedy at +1-480-985-9512 or Kayleen Kell at +1-888-290-2225 (USA only), or email IN3@Elsevier.com.

 

 

 

 

 

About Partnering

Important Deadlines
Save $100 before: 09/16/2010
Last Chance for Discounted Rooms (may sell out earlier) 10/05/2010
Partnering Opens (start scheduling meetings) 10/05/2010
Innovator Company Profile Due 10/05/2010

Click Here to view full pricing schedule.

Who Attends

  • • Presidents, Principals, CEOs, CTOs, COOs, CMOs
  • • Founders, Board Leaders, Chairpersons
  • • Venture Partners, Senior Investors, Private Equity, Angel Investors
  • • VPs/Directors of Strategic Planning, Business Development/Analysis, Marketing, New Technology, Acquisitions, R&D, Sales

From These Types of Companies

  • • Established, large device companies seeking technology via licensing, partnering, and acquisition to broaden or deepen product lines or build sector strength.
  • • VCs, private equity, investment firms/consultant, and investment banks.
  • • Medical device, biopharmaceutical, biotech, or other company executives seeking investments or partnerships.

Benefits of Attending

  • • More than 40 medical technology innovators give 10-minute presentations on their latest innovations within a wide range of high-growth markets.
  • • Nearly 15 finance presentations and perspectives by some of the industry's biggest players.
  • • Over two dozen networking opportunities without schedule overlap or program interrupt.
  • • Partnering Software to identify attendees and plan private, one-on-one meetings in advance.
    Learn more about the tremendous benefits!
  • • Keynote sessions on the latest 'deals' case studies, device investing, M&A, health reform, clinicians, and more!
  • • Cutting-edge news on investing and partnering, as driven by Elsevier Business Intelligence analysts.

About Partnering

Why Use Windhover Conferences Partnering Software?

  • • Identify attendees to choose potential partners.
  • • Search database of partnering/investing opportunities (including deal history and related articles).
  • • Communicate and pre-schedule as many meetings as you wish with fellow attendees.
  • • Showcase your company's innovative technology and investment/partnering interests.

More Info >>

Advisory Board

  • Annette Campbell-White
    Senior Managing Member
    MedVenture Associates
  • Michael Carusi
    General Partner
    Advanced Technology Ventures
  • Luke Evnin
    General Partner
    MPM Capital
  • Richard M. Ferrari
    Managing Director
    DeNovo Ventures
  • William T. Harrington
    Partner
    Three Arch Partners
  • Ross A. Jaffe
    Managing Director
    Versant Ventures
  • Josh Makower
    Venture Partner
    NEA
  • John Maroney
    General Partner
    Delphi Ventures
  • Allan May
    Chairman, Founder
    Life Science Angels
    Managing Director
    Emergent Medical Partner
  • David Milne
    Managing Partner
    SV Life Science Advisers
  • Trevor J. Moody
    Partner
    Frazier Healthcare Ventures
  • Jesse I Treu
    Partner
    Domain Associates